289 related articles for article (PubMed ID: 21680501)
41. Identification of a pH-Sensitive Switch in VSV-G and a Crystal Structure of the G Pre-fusion State Highlight the VSV-G Structural Transition Pathway.
Beilstein F; Abou Hamdan A; Raux H; Belot L; Ouldali M; Albertini AA; Gaudin Y
Cell Rep; 2020 Aug; 32(7):108042. PubMed ID: 32814045
[TBL] [Abstract][Full Text] [Related]
42. Inactivation of vesicular stomatitis virus through inhibition of membrane fusion by chemical modification of the viral glycoprotein.
Stauffer F; De Miranda J; Schechter MC; Carneiro FA; Salgado LT; Machado GF; Da Poian AT
Antiviral Res; 2007 Jan; 73(1):31-9. PubMed ID: 16934341
[TBL] [Abstract][Full Text] [Related]
43. Influence of membrane anchoring and cytoplasmic domains on the fusogenic activity of vesicular stomatitis virus glycoprotein G.
Odell D; Wanas E; Yan J; Ghosh HP
J Virol; 1997 Oct; 71(10):7996-8000. PubMed ID: 9311894
[TBL] [Abstract][Full Text] [Related]
44. Efficient export of the vesicular stomatitis virus G protein from the endoplasmic reticulum requires a signal in the cytoplasmic tail that includes both tyrosine-based and di-acidic motifs.
Sevier CS; Weisz OA; Davis M; Machamer CE
Mol Biol Cell; 2000 Jan; 11(1):13-22. PubMed ID: 10637287
[TBL] [Abstract][Full Text] [Related]
45. Role of viral envelope sialic acid in membrane fusion mediated by the vesicular stomatitis virus envelope glycoprotein.
Puri A; Grimaldi S; Blumenthal R
Biochemistry; 1992 Oct; 31(41):10108-13. PubMed ID: 1327132
[TBL] [Abstract][Full Text] [Related]
46. Mutations in a carboxy-terminal region of vesicular stomatitis virus glycoprotein G that affect membrane fusion activity.
Shokralla S; He Y; Wanas E; Ghosh HP
Virology; 1998 Mar; 242(1):39-50. PubMed ID: 9501039
[TBL] [Abstract][Full Text] [Related]
47. Specific targeting to CD4+ cells of recombinant vesicular stomatitis viruses encoding human immunodeficiency virus envelope proteins.
Johnson JE; Schnell MJ; Buonocore L; Rose JK
J Virol; 1997 Jul; 71(7):5060-8. PubMed ID: 9188571
[TBL] [Abstract][Full Text] [Related]
48. Role of heterologous and homologous glycoproteins in phenotypic mixing between Sendai virus and vesicular stomatitis virus.
Metsikkö K; Garoff H
J Virol; 1989 Dec; 63(12):5111-8. PubMed ID: 2555547
[TBL] [Abstract][Full Text] [Related]
49. Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector.
Keil W; Wagner RR
Virology; 1989 Jun; 170(2):392-407. PubMed ID: 2471352
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors.
Fang X; Zhang S; Sun X; Li J; Sun T
Vaccine; 2012 Feb; 30(7):1313-21. PubMed ID: 22222871
[TBL] [Abstract][Full Text] [Related]
51. Homotypic and heterotypic exclusion of vesicular stomatitis virus replication by high levels of recombinant polymerase protein L.
Meier E; Harmison GG; Schubert M
J Virol; 1987 Oct; 61(10):3133-42. PubMed ID: 3041035
[TBL] [Abstract][Full Text] [Related]
52. Fusion-active glycoprotein G mediates the cytotoxicity of vesicular stomatitis virus M mutants lacking host shut-off activity.
Hoffmann M; Wu YJ; Gerber M; Berger-Rentsch M; Heimrich B; Schwemmle M; Zimmer G
J Gen Virol; 2010 Nov; 91(Pt 11):2782-93. PubMed ID: 20631091
[TBL] [Abstract][Full Text] [Related]
53. Fatty acid acylation is not required for membrane fusion activity or glycoprotein assembly into VSV virions.
Whitt MA; Rose JK
Virology; 1991 Dec; 185(2):875-8. PubMed ID: 1660205
[TBL] [Abstract][Full Text] [Related]
54. Expression of human immunodeficiency virus type 1 Gag protein precursor and envelope proteins from a vesicular stomatitis virus recombinant: high-level production of virus-like particles containing HIV envelope.
Haglund K; Forman J; Kräusslich HG; Rose JK
Virology; 2000 Mar; 268(1):112-21. PubMed ID: 10683333
[TBL] [Abstract][Full Text] [Related]
55. E1 mutants identify a critical region in the trimer interface of the Semliki forest virus fusion protein.
Liu CY; Kielian M
J Virol; 2009 Nov; 83(21):11298-306. PubMed ID: 19692469
[TBL] [Abstract][Full Text] [Related]
56. A new approach to measure fusion activity of cloned viral envelope proteins: fluorescence dequenching of octadecylrhodamine-labeled plasma membrane vesicles fusing with cells expressing vesicular stomatitis virus glycoprotein.
Puri A; Krumbiegel M; Dimitrov D; Blumenthal R
Virology; 1993 Aug; 195(2):855-8. PubMed ID: 8393251
[TBL] [Abstract][Full Text] [Related]
57. Effects of double-site mutations of vesicular stomatitis virus glycoprotein G on membrane fusion activity.
Shokralla S; Chernish R; Ghosh HP
Virology; 1999 Mar; 256(1):119-29. PubMed ID: 10087232
[TBL] [Abstract][Full Text] [Related]
58. Conformational changes and fusion activity of vesicular stomatitis virus glycoprotein: [125I]iodonaphthyl azide photolabeling studies in biological membranes.
Pak CC; Puri A; Blumenthal R
Biochemistry; 1997 Jul; 36(29):8890-6. PubMed ID: 9220976
[TBL] [Abstract][Full Text] [Related]
59. In vitro cell-free conversion of noninfectious Moloney retrovirus particles to an infectious form by the addition of the vesicular stomatitis virus surrogate envelope G protein.
Abe A; Chen ST; Miyanohara A; Friedmann T
J Virol; 1998 Aug; 72(8):6356-61. PubMed ID: 9658075
[TBL] [Abstract][Full Text] [Related]
60. Structure of the prefusion form of the vesicular stomatitis virus glycoprotein G.
Roche S; Rey FA; Gaudin Y; Bressanelli S
Science; 2007 Feb; 315(5813):843-8. PubMed ID: 17289996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
